rs775404728
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM5PP3_ModeratePP5_Very_Strong
The NM_000256.3(MYBPC3):c.2458C>T(p.Arg820Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R820Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.2458C>T | p.Arg820Trp | missense_variant | 25/35 | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.2458C>T | p.Arg820Trp | missense_variant | 25/35 | 5 | NM_000256.3 | ENSP00000442795 | P4 | |
MYBPC3 | ENST00000399249.6 | c.2458C>T | p.Arg820Trp | missense_variant | 24/34 | 5 | ENSP00000382193 | A2 | ||
MYBPC3 | ENST00000544791.1 | c.2414-24C>T | intron_variant, NMD_transcript_variant | 5 | ENSP00000444259 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249210Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135184
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461686Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727124
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 4 Pathogenic:4
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Oct 08, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Breakthrough Genomics, Breakthrough Genomics | Jul 12, 2020 | This variant has been reported in the homozygous state in two related individuals affected with hypertrophic cardiomyopathy and left ventricular non-compaction; however, heterozygous carriers in this family were unaffected [PMID: 20542340]. Experimental studies have shown that felines with an equivalent variant develop hypertrophic cardiomyopathy [PMID: 17521870], however the clinical significance of this observation is uncertain. Another missense substitution at the same codon (p.Arg820Gln) has been reported as pathogenic [PMID: 12628722, 22112859, 22267749]. - |
not provided Pathogenic:2Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2019 | Reported in ClinVar (ClinVar Variant ID# 195850; Landrum et al., 2016); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30284024, 19566849, 26776581, 28868097, 21147473, 26776585, 25622655, 26776584, 27076529, 26776595, 24602043, 21051304, 24906243, 23323744, 17521870, 21415409, 24447051, 29907873, 19035361, 29636697, 28642712, 28679633, 28771489, 20542340) - |
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | May 04, 2015 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, flagged submission | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 17, 2019 | - - |
Cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Sep 03, 2021 | - - |
Hypertrophic cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 04, 2023 | This missense change has been observed in individuals with hypertrophic cardiomyopathy and/or left ventricular noncompaction (PMID: 20542340, 28771489, 33782553; Invitae). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 820 of the MYBPC3 protein (p.Arg820Trp). ClinVar contains an entry for this variant (Variation ID: 195850). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg820 amino acid residue in MYBPC3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12628722, 22112859, 22267749, 25281569). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects MYBPC3 function (PMID: 17521870, 24906243, 26776584). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2023 | The p.R820W variant (also known as c.2458C>T), located in coding exon 25 of the MYBPC3 gene, results from a C to T substitution at nucleotide position 2458. The arginine at codon 820 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration has been reported in the heterozygous and homozygous states in individuals with hypertrophic cardiomyopathy (HCM); however, heterozygous relatives of the homozygous proband were reportedly unaffected (Ripoll Vera T et al, Int. J. Cardiol. 2010 Nov; 145(2):405-7; Mademont-Soler I et al. PLoS ONE, 2017 Aug;12:e0181465; Chung H et al. Cardiovasc Ultrasound, 2021 Jan;19:4; Stava TT et al. Eur J Prev Cardiol. 2022 Oct;29(13):1789-1799; Ambry internal data). The same alteration (p.R820W) has also been detected in ragdoll cats exhibiting HCM (Meurs KM et al. Genomics, 2007 Aug;90:261-4). Another alteration at the same codon, p.R820Q (c.2459G>A), has been detected in individuals with HCM (Konno T et al. J. Am. Coll. Cardiol., 2003 Mar;41:781-6). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at